How Marc Beer Achieved Success In The Biotechnology Industry
Since 1973, biotechnology continues to advance after the invention of genetic engineering to
create new products and improvement of health. Biotech is a part of human life involving food and
health. Entrepreneur Marc Beer, the CEO and Chairman of Renovia, Inc. is no stranger to the
development and commercialization of biotechnology and pharmaceutical devices and diagnostics.
His compassion for healthcare began after earning a BS in Business from Miami University working
for companies in sales and marketing. Blogwebpedia describes Beer as a champion in the biotech
industry because of his expertise and accomplishments as an American businessman.
The beginning career of Marc Beer started in the pharmaceutical sales and marketing industries, in
the United States. He held executive roles for companies such as Genzyme where he served as
vice-president of global marketing. Marc worked for Abbott Laboratories in the pharmaceutical and
diagnostic divisions. In 2000, he was ready to explore entrepreneurship and started Via-Cell, a
biotechnology company. Under his leadership, the business went public within five years and by
2007 it was worth $300 million with 300 workers.
Marc Beer sold Via-Cell and found other companies including Minerva Neurosciences, a
biopharmaceutical company and Good Start Genetics, a molecular diagnostics business. Amid his
business ventures, he took some time off from work to spend with his family for some years before
starting a med-tech company, in 2016. Beer co-founded Renovia with partners, Yolanda Lorie and
Dr. Iglesias in Boston, MA. Their mission is to help women with pelvic floor disorders restore health
through muscle strengthening solutions.
Most women who have pelvic floor disorders are pre-menopausal with urinary incontinence (UI).
Some causes of the disorder could be endometriosis, uterine fibroid, digestive diseases, or chronic
pelvic inflammatory disease. Marc Beer and his partners are working to improve treatments and
diagnosis with the combination of technologies and a digitized health forum. It will produce
important information to help Renovia produce specific treatments for each patient, resulting in
lowering costs for long-term healthcare.
Learn more: https://blogwebpedia.com/marc-beer-entrepreneurial-spirit-biotech.html
The Food and Drug Administration approved Renovia’s Leva pelvic digital therapeutic device with
the smart phone app in 2018. Marc Beer is guiding the company in the production, research, and
testing of Leva products. In a recent study, published by Neurology and Urodynamics the results
showed improvements in the health of women with pelvic floor disorders using the pelvic digital
therapeutic devices. Most participants in the study had no problems and reported the device is
simple to use in an outpatient facility or in the home environment. Mr. Beer has a proven track
record of running successful businesses and leading them to the forefront of the biotechnology and